Glipzide
is a medication used in the treatment of patients with part 2 diabetes it is a
medium to long lasting tablet that is classed as a second generation
sulfonylurea.
It was first marketed by Pfizer using the name Glucotrol in
America where it was sold in doses of 5mg or 10mg and an extended time release
version called Glucotrol XL of 2.5mg 5mg and 10mg. Other companies now market
Glipzide but in 5mg and 10mg doses only. Glipizide
is a second generation Sulfonylureas used to treat patients who have type 2
diabetes. It works by helping to control the amount of insulin the pancreas
produces, and helps to control glucose in the blood stream.
